Apellis Pharmaceuticals (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trading Halts

Wedbush Downgrades Apellis Pharmaceuticals (APLS) to NeutralSeptember 10, 2021 7:29 AM Apellis Pharmaceuticals (APLS) PT Lowered to $65 at OppenheimerSeptember 10, 2021 6:58 AM Apellis Pharmaceuticals (APLS) PT Lowered to $70 at Needham & CompanySeptember 10, 2021 6:54 AM Apellis Pharmaceuticals (APLS) PT Lowered to $69 at BMO Capital, Overall Data 'Should Still be Enough'September 10, 2021 6:40 AM UPDATE: IVERIC bio (ISEE) Gains Following Results From Apellis Pharmaceuticals (APLS)September 9, 2021 4:14 PM Form 8-K Apellis Pharmaceuticals, For: Sep 09September 9, 2021 4:11 PM Apellis Pharmaceuticals (APLS) Announces Results of Phase 3 DERBY and OAKS Studies in Geographic Atrophy, Plans NDASeptember 9, 2021 4:06 PM Apellis Announces Top-Line Results from Phase 3 DERBY and OAKS Studies in Geographic Atrophy (GA) and Plans to Submit NDA to FDA in the First Half of 2022September 9, 2021 4:05 PM